|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Axiilary lymph node nano metastases are prognostic factors for metastatic relapse in breast cancer patients显示文摘 | Alberti S Querzoli P Pedriali M | 2006 | Breast cancer Res Treat2006，100，1： | 1 |
| 2 | Combined experimental and numerical analysis of the flow structure into the left ventricle显示文摘 | Domenichini F Querzoli G Cenedese A | | 0，，09： | 1 |
| 3 | Axillary lymph node nanome- tastases are prognostic factors for metastatic relapse in breast cancer patients 显示文摘 | Querzoli P Pedriali M Rinaldi R | 2006 | Clin Cancer Res2006，15，12： | 1 |
| 4 | 90K(MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 显示文摘 | Fusco O Querzoli P Nenci I | 1998 | Int J Cancer1998，79，1： | 1 |
| 5 | Primary breast cancer features can predict additional lymph node involvement in patiets with sentinel node micro- metastases显示文摘 | Carcoforo P Maestroni U Querzoli P | 2006 | World Journal of Surgery2006，30，9： | 1 |
| 6 | Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer显示文摘Dear Editor,In early breast cancer,the prognostic value of the num-ber of macroscopically metastasized axillary nodes has been recognized in earlier reports[1].However,the impact of microscopic tumour cell deposits on the sur-vival outcome of early breast cancer patients is still debated[2].This issue has gained increasing attention since the implementation of sentinel node biopsy in axil-lary node staging for tailoring breast cancer treatments,and the status of the single resected node would deter-mine the clinical decision of whether or not to perform the axillary lymph node dissection[3].Moreover,this issue raises more questions on whether to administer primary or adjuvant systemic treatment for patients with lymph nodes bearing isolated tumour cells(pN0[i+])or micrometastases(pN1mi).Despite the wide debate on the clinical treatment dilemma encountered by early breast cancer patients with microscopic tumour cell deposits,the biology underlying different pathologi-cal presentations at microscopic level(pN0,pN0[i+],pN1mi)and the disease outcomes remain poorly known.In an attempt to shed some light on this topic,we have analyzed,in the context of dormancy-based metastasis development model[4],early breast cancer patients con-ventionally classified as pN0(tumour foci with largest diameter≤2 mm)[5]by systematically reassessing their tumor recurrence dynamics following primary tumour resection at a single institution. | Romano Demicheli Marco Fornili Patrizia Querzoli Massimo Pedriali Saverio Alberti Christine Desmedt Elia Biganzoli | 2019 | Cancer Communications2019，39，1： | 1 |
| 7 | Axillary lymphnode nanometastases are prognostic factors for metastaticrelapse in breast cancer patients显示文摘 | Querzoli P Pedriali M Rinaldi R | 2006 | Clin Cancer Res2006，15，12： | 1 |
| 8 | Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 显示文摘 | Albonico G Querzoli P Feretti S | 1996 | Pathol Res Pract1996，192，2： | 1 |
| 9 | Biological pro- file of in situ breast cancer investigated by immunohisto- chemical technique 显示文摘 | Albonico G Querzoli P Ferretti S | 1998 | Cancer Detect Prey1998，22，4： | 1 |
| 10 | Ultrasound imaging velocimetry of the human vitreous显示文摘 | Rossi T Querzoli G Pasqualitto G | | 0，，： | 1 |
| 11 | An immunohisto- chemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 显示文摘 | QUERZOLI P CORADINI D PEDRIALI M | 2010 | British Journal of Canc- er2010，103，： | 1 |
| 12 | Biological profile of in situ breast cancer investigated by immunohistochemical technique显示文摘 | Albonico G Querzoli P Ferretti S | 1998 | Cancer Detect Prev1998，22，4： | 1 |
| 13 | MicroRNAs: toward the clinic for breast cancer patients 显示文摘 | Ferraein M Querzoli P Calin GA | 2011 | Semin Oncol2011，38，6： | 1 |
| 14 | Axillary lymph node nano- metastases are prognostic faetors for disease-free survival and metastat- ic relapse in breast cancer patients 显示文摘 | Querzoli P Pedriali M Rinaldi R | 2006 | Clin Cancer Res2006，12，22： | 1 |
| 15 | 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 显示文摘 | Fusco O Querzoli P Nenci I | 1998 | Int J Cancer1998，79，1： | 1 |
| 16 | Axillary lymph node nanometastases are prognostic factors for metastatic relapse in breast cancer patients 显示文摘 | Querzoli P Pedriali M Rinaldi R | 2006 | Clin Cancer Res2006，12，22： | 1 |
| 17 | Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases 显示文摘 | Carcoforo P Maestroni U Querzoli P | 2006 | World J Surg2006，30，9： | 1 |
| 18 | Application of quantitalive analysis tobiologic profile evaluation in breast cancer显示文摘 | Querzoli P Ferretli S Albonico G | 1995 | Cancer1995，76，12： | 1 |
| 19 | MicroRNAs:toward the clinic for breast cancer patients显示文摘 | Ferracin M Querzoli P Calin GA | 2011 | Oncol Rep2011，25，5： | 1 |
| 20 | Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases显示文摘 | Carcoforo P Maestroni U Querzoli P | 2006 | World J Surg2006，30，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员